Omicron, the vaccine we failed to make

Omicron now and risky London research

https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---30-march-2023

Covid, 3.6 million new cases (down 27% on the month)

25 000 deaths (down 39% on the month)

Hospital admissions, down 9%

ICU admissions down 5%

As of 26 March 2023

761 million confirmed cases

6.8 million deaths

Current trends in reported COVID-19 cases are underestimates of the true number of global infections and reinfections.

Variants, geographic spread and prevalence

27 February to 26 March 2023 (28 days),

54, 922 SARS-CoV-2 sequences

WHO closely tracking variant of interest, XBB.1.5

Six variants under monitoring (VUMs).

BQ.1, BA.2.75, CH.1.1, XBB, XBF and XBB.1.16

XBB.1.16 is a recombinant of BA.2.10.1 and BA.2.75

(three additional mutations in the SARS-CoV-2 spike protein)

Reports do not indicate a rise in hospitalizations, ICU admissions, or deaths due to XBB.1.16.

Globally

XBB.1.5 accounts for 45.1% of cases

BQ.1, BA.2.75 declined

CH.1.1 and XBF remained stable

Civil Service, long covid, September and October 2022

https://www.telegraph.co.uk/politics/2023/03/31/twice-as-many-civil-servants-long-covid-national-average/

10 – 10.8 %, declared the condition in autumn 2022

7.4 % affecting their day-to-day life

(3.3 % of the general public)

Year to March 2022

Poor mental health

Musculoskeletal problems

Others

Long covid

Periods off sick, less than 20 working days

32.4 % of all absences